Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...

I have no access to any of the numerous products I purchased, way back in 2018. The products on the app were avail for a couple of yrs, then stopped working. I have been trying to contact this company ...